Search research articles
Contact Us
Filters
Showing results (121-130 of 223) with videos related to
Page
of 23
Sort By:
Translational Lung Cancer Research
|
February 4, 2020
Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer
Guanghui Gao, Keyi Jia, Sha Zhao, et al.
Cancer Medicine
|
June 26, 2024
A retrospective study of first-line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations
Li Wang, Yueran Wu, Zhixuan Ren, et al.
BMC Medicine
|
July 28, 2022
Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer
Juan Zhou, Minwei Bao, Guanghui Gao, et al.
Experimental Hematology & Oncology
|
July 19, 2023
Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway
Fei Zhou, Jianguo Sun, Lingyun Ye, et al.
Frontiers in Immunology
|
May 16, 2020
<sup>1</sup>IFN-α Modulates Memory Tfh Cells and Memory B Cells in Mice, Following Recombinant FMDV Adenoviral Challenge
Xiangguo Duan, Peng Sun, Yaru Lan, et al.
Journal of Nanobiotechnology
|
June 1, 2021
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis
Yan Zhang, Yifei Yin, Wei Zhang, et al.
International Immunopharmacology
|
February 3, 2020
Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells
Xiangguo Duan, Chunxiu Shen, Xiaoyu Zhang, et al.
Frontiers in Oncology
|
September 28, 2020
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With <i>EGFR</i> Mutations
Yijun Jia, Xuefei Li, Chao Zhao, et al.
ACS Applied Materials & Interfaces
|
December 22, 2025
Biological Nanocarrier-Based Therapy for Breast Cancer Using Modified <i>Faecalibaculum rodentium</i>-Derived Bacterial Membrane Vesicles
Jiayu Liu, Jiao Zhang, Yongsheng Zhou, et al.
Immunobiology
|
March 27, 2024
The changes of intestinal flora and its relevance with memory Tfh and B cells in rheumatoid arthritis patients treated with csDMARDs and csDMARDs + bDMARDs
Chunlei Jiang, Shuhong Chi, Fengkui Wang, et al.
Page
of 23
Search research articles
Search
Showing results (121-130 of 223) with videos related to
Sort By:
Page
of 23
Translational Lung Cancer Research
|
February 4, 2020
Analysis of the association between prior chemotherapy regimens and outcomes of subsequent anti-PD-(L)1 monotherapy in advanced non-small cell lung cancer
Guanghui Gao, Keyi Jia, Sha Zhao, et al.
Cancer Medicine
|
June 26, 2024
A retrospective study of first-line therapy and subsequent pyrotinib treatment in advanced lung adenocarcinoma with HER2 mutations
Li Wang, Yueran Wu, Zhixuan Ren, et al.
BMC Medicine
|
July 28, 2022
Increased blood-based intratumor heterogeneity (bITH) is associated with unfavorable outcomes of immune checkpoint inhibitors plus chemotherapy in non-small cell lung cancer
Juan Zhou, Minwei Bao, Guanghui Gao, et al.
Experimental Hematology & Oncology
|
July 19, 2023
Fibronectin promotes tumor angiogenesis and progression of non-small-cell lung cancer by elevating WISP3 expression via FAK/MAPK/ HIF-1α axis and activating wnt signaling pathway
Fei Zhou, Jianguo Sun, Lingyun Ye, et al.
Frontiers in Immunology
|
May 16, 2020
<sup>1</sup>IFN-α Modulates Memory Tfh Cells and Memory B Cells in Mice, Following Recombinant FMDV Adenoviral Challenge
Xiangguo Duan, Peng Sun, Yaru Lan, et al.
Journal of Nanobiotechnology
|
June 1, 2021
Reactive oxygen species scavenging and inflammation mitigation enabled by biomimetic prussian blue analogues boycott atherosclerosis
Yan Zhang, Yifei Yin, Wei Zhang, et al.
International Immunopharmacology
|
February 3, 2020
Toll-like receptor 7 agonist imiquimod prevents the progression of SLE in MRL/lpr mice via inhibiting the differentiation of T follicular helper cells
Xiangguo Duan, Chunxiu Shen, Xiaoyu Zhang, et al.
Frontiers in Oncology
|
September 28, 2020
Soluble PD-L1 as a Predictor of the Response to EGFR-TKIs in Non-small Cell Lung Cancer Patients With <i>EGFR</i> Mutations
Yijun Jia, Xuefei Li, Chao Zhao, et al.
ACS Applied Materials & Interfaces
|
December 22, 2025
Biological Nanocarrier-Based Therapy for Breast Cancer Using Modified <i>Faecalibaculum rodentium</i>-Derived Bacterial Membrane Vesicles
Jiayu Liu, Jiao Zhang, Yongsheng Zhou, et al.
Immunobiology
|
March 27, 2024
The changes of intestinal flora and its relevance with memory Tfh and B cells in rheumatoid arthritis patients treated with csDMARDs and csDMARDs + bDMARDs
Chunlei Jiang, Shuhong Chi, Fengkui Wang, et al.
Page
of 23